NPPA and depressive symptom measurement: Decreased levels of this intermediate KP metabolite are present in blood of patients that suffered a stroke, had a chronic brain injury or coronary bypass, but levels are higher in patients suffering from Huntington’s Disease (HD) or depression [142].